GLP-1 medications aren’t just a trend; they’re quickly becoming the new weight-loss standard. And the demand is only growing. As more employees turn to these medications, HR leaders should proactively consider how to support employees’ long-term success. While GLP-1s are powerful, they’re not a standalone solution. Fitness benefits are key to maximizing their effectiveness. Explore the latest workplace trends and discover how tailored fitness benefits can enhance outcomes and support employees’ health over the long term.
GLP-1s in the Workplace: A Growing Trend
Once a niche treatment, GLP-1 medications are becoming more common in the workplace. One in eight adults report using a GLP-1 drug, and public awareness is high—about three-quarters of Americans say they’ve heard of Ozempic®, Wegovy®, and similar medications. Furthermore, among those familiar with the drugs, 53% believe they’re a good option for those with obesity or weight-related conditions.
The trend is set to continue, with over 16 new weight-loss drugs expected by 2029. Pharmaceutical companies are racing to develop alternatives to injections, making the treatment increasingly accessible and easier to use.
The Future of Medications in Employee Benefits
As interest in GLP-1s grows, so does employer coverage, although cost remains a concern. While the medications deliver impressive results for weight loss and related health conditions, companies are carefully evaluating the financial implications before expanding benefits. Here’s a look at the latest trends:
- Growing Demand: 79% of employers report increased interest in obesity medications from their covered members.
- Expanding Coverage: Approximately 34% of employers cover GLP-1 medications for weight loss, up from 26% in 2023.
- Large Employers Leading the Way: Among companies with 500+ employees, 44% offer obesity medication coverage, up from 41% in 2023. The largest employers are moving even faster, with 64% now covering GLP-1s for obesity treatment, up from 56% the previous year.
- What’s Ahead: Employer interest is projected to continue growing, with over a quarter of companies considering adding obesity medication coverage by 2025 or 2026.
Fitness Benefits: Amplifying Results
While GLP-1 medications can trigger weight loss without making lifestyle changes, experts agree that combining them with regular exercise and a balanced diet is essential for optimal results. It’s clear that combining the two creates a synergy that enhances the effectiveness of the medications.
Individuals who don’t exercise while taking GLP-1 medications can lose a lot of muscle mass as they lose weight quickly. Exercise, particularly strength training and low-intensity or moderate aerobic activity, helps preserve lean muscle during weight loss.
Moreover, establishing a regular exercise routine during GLP-1 treatment can help prevent weight regain, which can be a challenge once the medication is stopped.
Easing Employees into Exercise
Many employees on GLP-1 medications may not be regular exercisers. Taking that first step can be daunting for those new to exercise or hesitant to begin. The good news is that there are practical strategies to ease even the most reluctant employees into a fitness routine.
Aaptiv: The Ideal Companion for Employees on GLP-1s
Aaptiv’s digital audio and video fitness app is an ideal solution for employees taking weight-loss medication. The AI-driven program provides exercise plans tailored to each employee’s fitness level, regardless of where they are in their health journey. The easy-to-use app then continuously adapts the plan based on user feedback, ensuring the most effective and motivating workouts.
GLP-1 medications are undeniably effective and are expected to continue growing in popularity. Employers can amplify their impact by offering fitness benefits, ensuring their employees have the tools they need to achieve and maintain better health in the long term.
